SAVE THE DATES
5th International Congress on Deuterium Depletion (ICDD2026)
The International Congress on Deuterium Depletion focuses on the latest advances in deuterium depletion research, with a strong emphasis on its present and future role in cancer research and oncotherapy, diabetes research, mental health, physical performance, health preservation, and anti-aging.
Medicilon, a leading integrated preclinical contract research organization (CRO), is pleased to announce its participation in the ICDD2026, taking place on April 22–23, 2026 in Budapest, Hungary.
Where
Budapest, Hungary
When
April 22-23, 2026
Meet our team on site:
Marshal Ma – VP of Strategic Alliances & Business Development
Nadine Su – VP of Strategic Alliances & Business Development
Both executives will be on-site throughout the event, ready to connect with research partners, pharmaceutical companies, and academic institutions. They look forward to exploring strategic collaborations and discussing how Medicilon’s comprehensive preclinical capabilities can accelerate your deuterium depletion-based therapeutic programs.
Why Partner with Medicilon?
With over 20 years of experience and a proven track record of supporting more than 620 IND filings globally, Medicilon offers a true one-stop solution from drug discovery to IND-enabling studies:
- Drug discovery: Medicinal chemistry, biology, hit-to-lead optimization
- Pharmaceutical development: API process development, CMC, formulation
- Preclinical Research: pharmacology, toxicology, DMPK, safety evaluation
- Regulatory Support: IND filing assistance for global submissions
We also have dedicated platforms for next-generation modalities including ADCs, AOCs, PROTACs, mRNA vaccines, oligonucleotides, CGT, and AI‑driven drug discovery platform.
With global regulatory capabilities (FDA, NMPA, OECD), we support global IND filings and flexible collaboration models (FTE/FFS). To date, we have assisted 610+ IND applications receive clinical trial approval.
We’re eager to connect with partners, explore collaboration opportunities, and drive innovation in drug discovery & development together.
